Advanced colorectal neoplasia

There are 25 papers on advanced colorectal neoplasia in aging research: 1 trial and 19 observational studies in people, 5 reviews.

Disease

25 papers study it16 more mention it15 findings

8 new papers in 30 daysSee all 41 papers on advanced colorectal neoplasia

“Multivariate analysis showed that MAFLD was independently associated with increased ACN risk (OR = 1.20, P < 0.05).”
Metabolic dysfunction-associated fatty liver disease is an independent risk factor for advanced colorectal adenoma or cancerEuropean journal of gastroenterology & hepatology2026doi:10.1097/meg.0000000000003148
  • Human trial1
  • Humans19

Upstream

1

3-4 non-advanced adenomas

no changein humans1HR 0.64

1 study
  1. 3-4 non-advanced adenomas were not clearly linked with advanced colorectal neoplasia in humans (vs individuals with 1-2 NAAs) (adjusted HR 0.64, 95% CI 0.18-2.23).

    “the cumulative incidence and risk of metachronous ACRN in individuals with 1-2 NAAs was comparable with that in those with 3-4 NAAs (adjusted HR (95% CI), 0.64(0.18-2.23))”

    Humansvs individuals with 1-2 NAAsn = 2,955

    Risk of metachronous advanced neoplasia was comparable between patients with 1-2 and 3-4 non-advanced adenomas removed during screening colonoscopy

    Surgical endoscopy

Associations

13

Sarcopenia

upin humans2OR 1.97–2.347

2 studies
  1. Sarcopenia is linked with a higher risk of advanced colorectal neoplasia in humans (multivariate analysis adjusting for confounding factors, ASM/BMI criteria) (OR 1.97, 95% CI 1.27-3.06).

    “and advanced colorectal neoplasia (OR, 1.97; 95% CI, 1.27 to 3.06).”

    Humansmultivariate analysis adjusting for confounding factors, ASM/BMI criterian = 10,676

    Prevalence and associated risk of advanced colorectal neoplasia in adults with sarcopenia

    The Korean journal of internal medicine

  2. Sarcopenia is associated with advanced colorectal neoplasia in humans (Adjusted for variable confounders) (OR 2.347, 95% CI 1.311–4.202; P = 0.004).

    “sarcopenia (odds ratio 2.347, 95% confidence interval 1.311-4.202; P = 0.004) were associated with an advanced colorectal neoplasia.”

    HumansAdjusted for variable confoundersn = 1,270

    Sarcopenia is associated with an increased risk of advanced colorectal neoplasia

    International journal of colorectal disease

More on Sarcopenia

APCS + FIT + mSEPT9 model

upin humans1

1 study
  1. APCS + FIT + mSEPT9 model predicts advanced colorectal neoplasia in humans (high-risk population; internal bootstrap validation) (Optimism-corrected AUC 0.886; apparent AUC 0.912; sensitivity 91.1% and specificity 68.6% at cutoff 0.318).

    “The optimism‐corrected AUC was 0.886 for the triple model and 0.852 for APCS + FIT”

    Humanshigh-risk population; internal bootstrap validationn = 115

    Integrating <scp>APCS</scp> Score With Dual Biomarker Testing ( <scp>FIT</scp> + <scp>mSEPT9</scp> ) for Precision Risk Stratification and Predictive Modeling in High‐Risk Populations for Colorectal Cancer

    Annals of gastroenterological surgery

More on APCS + FIT + mSEPT9 model

Fecal immunochemical test

upin humans1

1 study
  1. Fecal immunochemical test predicts advanced colorectal neoplasia in humans (high-risk population) (AUC 0.836 (95% CI, 0.762–0.910)).

    “Quantitative FIT yielded an AUC of 0.836 (95% CI, 0.762–0.910).”

    Humanshigh-risk populationn = 115

    Integrating <scp>APCS</scp> Score With Dual Biomarker Testing ( <scp>FIT</scp> + <scp>mSEPT9</scp> ) for Precision Risk Stratification and Predictive Modeling in High‐Risk Populations for Colorectal Cancer

    Annals of gastroenterological surgery

More on Fecal immunochemical test

Asia-Pacific Colorectal Screening score

upin humans1

1 study
  1. Asia-Pacific Colorectal Screening score predicts advanced colorectal neoplasia in humans (asymptomatic individuals undergoing screening colonoscopy) (1.6% vs 6.7% vs 16.0%).

    “In the 825 individuals undergoing screening colonoscopy, ACN detection rates increased across APCS risk categories (average: 1.6%, moderate: 6.7%, high: 16.0%; p < 0.001).”

    Humansasymptomatic individuals undergoing screening colonoscopyn = 825

    Risk Stratification Using the Asia-Pacific Colorectal Screening Score in Asymptomatic and Fecal Immunochemical Test-Positive Individuals in Japan

    Digestion

More on Asia-Pacific Colorectal Screening score

Multivariable fractional-polynomial interaction model

upin humans1

1 study
  1. multivariable fractional-polynomial interaction model predicts advanced colorectal neoplasia in humans (derivation cohort) (AUC 0.76 (95% CI 0.72-0.81)).

    “The model achieved AUCs of 0.76 (95% CI 0.72-0.81) in the derivation cohort”

    Humansderivation cohortn = 715

    Risk-Based Colonoscopy Prioritization Model for Advanced Colorectal Neoplasia: Development and Validation Study

    Journal of gastroenterology and hepatology

Advanced colorectal neoplasia risk stratification model

upin humans1

1 study
  1. Advanced colorectal neoplasia risk stratification model predicts advanced colorectal neoplasia in humans (AUROC = 0.870).

    “The model demonstrated strong predictive performance (AUROC = 0.870) and good calibration (P = 0.929).”

    Humans

    Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

More on Advanced colorectal neoplasia risk stratification model

> 4 non-advanced adenomas

upin humans1HR 4.69

1 study
  1. > 4 non-advanced adenomas are linked with a higher risk of advanced colorectal neoplasia in humans (vs individuals with 1-2 NAAs) (adjusted HR 4.69, 95% CI 1.51-14.6).

    “and significantly lower than that in those with > 4 NAAs (adjusted HR (95% CI), 4.69(1.51-14.6))”

    Humansvs individuals with 1-2 NAAsn = 2,955

    Risk of metachronous advanced neoplasia was comparable between patients with 1-2 and 3-4 non-advanced adenomas removed during screening colonoscopy

    Surgical endoscopy

Colorectal serrated lesion

upin humans1OR 1.94

1 study
  1. Colorectal serrated lesion is associated with advanced colorectal neoplasia in humans (OR, 1.94; 95% CI, 1.24-3.02).

    “Detection of proximal SLs was associated with synchronous advanced colorectal neoplasia (OR, 1.94; 95% CI, 1.24-3.02 and 1.90; 1.18-3.07, respectively).”

    Humansn = 965

    High Detection Rates and Associated Factors of Colorectal Serrated Lesions: A Multicenter Prospective Study in the Asia-Pacific

    The American journal of gastroenterology

More on Colorectal serrated lesion

Low-grade colorectal dysplasia

upin humans1

1 study
  1. Low-grade colorectal dysplasia is associated with advanced colorectal neoplasia in humans (Inflammatory bowel disease; baseline low-grade dysplasia compared with no dysplasia) (aHR 3.51, 95% CI 2.77–4.45; 8.3% versus 2.3%).

    “8.3% of patients with LGD (aHR, 3.51; 95% CI, 2.77-4.45).”

    HumansInflammatory bowel disease; baseline low-grade dysplasia compared with no dysplasiaMedian follow-up of 13.3 yearsn = 1,031

    Incidence and Risk of Colorectal Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

More on Low-grade colorectal dysplasia

Indefinite colorectal dysplasia

upin humans1

1 study
  1. Indefinite colorectal dysplasia is associated with advanced colorectal neoplasia in humans (Inflammatory bowel disease; baseline indefinite dysplasia compared with no dysplasia) (aHR 1.85, 95% CI 1.09–3.15; 5.3% versus 2.3%).

    “2.3% of patients with ND had future advanced CRN compared with 5.3% of patients with IND (aHR, 1.85; 95% CI, 1.09-3.15)”

    HumansInflammatory bowel disease; baseline indefinite dysplasia compared with no dysplasiaMedian follow-up of 13.3 yearsn = 264

    Incidence and Risk of Colorectal Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

More on Indefinite colorectal dysplasia

All 13

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 6Mar 2026: 8Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 2Aug 2026: 3Sep 2026: 5Oct 2026: 4Nov 2026: 332 papers in 12 months

See all 41 papers on advanced colorectal neoplasia